Article | February 8, 2024

FSP Trends Report

Business Growth-GettyImages-1387469502

In the increasingly demanding realm of clinical research, where trials are becoming more intricate, drug developers are under mounting pressure to ensure the timely and cost-effective execution of studies, thus expediting therapeutic advancements.

The 2024 FSP Trends Report from the PPD™ clinical research division of Thermo Fisher Scientific delves into the burgeoning adoption of functional service provider (FSP) arrangements as a means to navigate the complexities and hurdles of the pharmaceutical landscape. FSP arrangements have emerged as a vital tactic for biotech and biopharma enterprises to tap into supplementary expertise and resource adaptability necessary for meeting project timelines.

Moreover, innovative providers are introducing new, globally-oriented FSP strategies aimed at keeping their clientele at the forefront of industry evolution. This report delves into various aspects including the current utilization and anticipated growth trajectory of FSPs in clinical research, the forthcoming trends in FSP strategies and models, and the essential components for effectively harnessing an FSP model to drive punctual and cost-efficient project delivery.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader